glutathione and cancer riskbmj Diet, nutrition, risk: what do we know and what is the way forward? KRAS-targeted therapies in cancer: novel
KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression Archives of Toxicology Springer Nature Link Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management The BMJ Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response Journal for ImmunoTherapy of Cancer
Pay in 4 interest-free payments of $5.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



